Literature DB >> 19756330

Recent trends in lung cancer and its association with COPD: an analysis using the UK GP Research Database.

Victor A Kiri1, Joan Soriano, George Visick, Leonardo Fabbri.   

Abstract

BACKGROUND: The association between lung cancer and COPD has not been investigated in the primary care setting.
METHOD: We determined the recent trends of lung cancer in COPD patients in the UK during the period 1991-2004, by investigating the population aged 45 and over in the General Practice Research Database.
RESULTS: The annual-incidence rates of lung cancer per 10,000 person-years were at least four-fold higher in patients with prior COPD (increasing from 45 to 64 in men; 29 to 48 in women) compared with the general population (from 10 to 15 in men; 5 to 10 in women). These lung cancer trends had significant annual increases that were similar in men (5%) and in women (5.5%) with prior COPD; in contrast, the annual increases of lung cancer incidence rates in the general population differed by gender, being 4% in men but double in women (8%). The three-year survival for lung cancer patients among those with prior COPD was almost half that of the general population (15% versus 26%; p<0.01) and the highest mortality was observed in men aged 45-64 (83.79 per 100 person-years; 95% CI: 69.66-97.92).
CONCLUSION: These results support the association of COPD and lung cancer observed in other settings.

Entities:  

Mesh:

Year:  2010        PMID: 19756330      PMCID: PMC6827612          DOI: 10.4104/pcrj.2009.00048

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  38 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

2.  COPD Overlap Syndromes: Asthma and Beyond.

Authors:  Allison A Lambert; Mark T Dransfield
Journal:  Chronic Obstr Pulm Dis       Date:  2016-01-15

3.  The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection.

Authors:  Rihong Zhai; Xiaojin Yu; Andrea Shafer; John C Wain; David C Christiani
Journal:  Chest       Date:  2014-02       Impact factor: 9.410

4.  The relationship between chronic obstructive pulmonary disease and lung cancer in African American patients.

Authors:  Nader Mina; Ayman O Soubani; Michele L Cote; Tariq Suwan; Angie S Wenzlaff; Sunil Jhajhria; Husam Samarah; Ann G Schwartz
Journal:  Clin Lung Cancer       Date:  2011-11-29       Impact factor: 4.785

5.  Increased lung cancer risk among patients with pneumococcal pneumonia: a nationwide population-based cohort study.

Authors:  Te-Yu Lin; Wen-Yen Huang; Jung-Chung Lin; Cheng-Li Lin; Fung-Chang Sung; Chia-Hung Kao; Jun-Jun Yeh
Journal:  Lung       Date:  2013-10-23       Impact factor: 2.584

6.  RNA-sequencing studies identify genes differentially regulated during inflammation-driven lung tumorigenesis and targeted by chemopreventive agents.

Authors:  Xuemin Qian; Ali Khammanivong; Jung Min Song; Fitsum Teferi; Pramod Upadhyaya; Erin Dickerson; Fekadu Kassie
Journal:  Inflamm Res       Date:  2015-03-21       Impact factor: 4.575

7.  Combining COPD with clinical, pathological and demographic information refines prognosis and treatment response prediction of non-small cell lung cancer.

Authors:  Joseph Putila; Nancy Lan Guo
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

8.  Prognostic implication of FEV1/FVC ratio for limited-stage small cell lung cancer.

Authors:  Oyeon Cho; Young-Taek Oh; Mison Chun; O Kyu Noh; Jae-Sung Heo
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

9.  Correlation in gene expression between the aggravation of chronic obstructive pulmonary disease and the occurrence of complications.

Authors:  Yuchen Cai; Runhan Liu; Xinhe Lu; Qiming Zhang; Xinwei Wang; Huijing Lian; Haohua Wang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

10.  Randomized phase III study comparing the first-line chemotherapy regimens in patients with driver mutation-negative advanced non-small cell lung cancer and poor performance status complicated with chronic obstructive pulmonary disease.

Authors:  Guoying Gao; Chengzhi Zhou; Yucheng Huang; Ziying Hong; Pei Yu; Ying Chen; Jiabo Gao; Kening Zhang; Zhanhong Xie; Jiexia Zhang; Shiyue Li; Nagata Masashi; Yinyin Qin
Journal:  Transl Lung Cancer Res       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.